Mylan says Teva's stake buy violates U.S. anti-trust rules

June 1, 2015 10:01 PM

40 0

Mylan says Teva's stake buy violates U.S. anti-trust rules

Mylan NV (MYL.O) said Teva Pharmaceutical Industries Ltd (TEVA.TA) (TEVA.N), which has made an unsolicited offer for the company, violated U.S. anti-trust rules by acquiring a stake.

"We consider Teva's stakebuilding as a further indication of its intention to meddle with our business, strategy and mission while remaining unclear as to its actual intentions," Mylan said in a letter addressed to Teva's chief executive, Erez Vigodman.(1.usa.gov/1Q0SxgC)

Read more

To category page

Loading...